“While the jury’s $130 million verdict is significant and may sound large in the abstract, it may not be enough without enhancement to deter infringing conduct given the context of this case,” Judge Olguin wrote. Evidence presented at trial shows that the infringing products sold by Cochlear generated $1.8 billion in revenues. Cochlear had publicly stated in a 2016 annual report that the jury’s verdict won’t disrupt Cochlear’s business or U.S. customers.
The post Judge Awards Enhancement of Damages to $268 Million in Cochlear Implant Patent Case appeared first on IPWatchdog.com | Patents & Patent Law.

Full Article Available Here